Liver transplantation for the Budd-Chiari syndrome

Glenn Halff, Satoru Todo, Andreas G. Tzakis, Robert D. Gordon, Thomas E. Starzl

Resultado de la investigación: Articlerevisión exhaustiva

163 Citas (Scopus)

Resumen

A retrospective study was performed that analyzed 23 patients who had an orthotopic liver transplantation for the Budd-Chiari syndrome with end-stage liver disease. Patient follow-up was as long as 14 years. The technical considerations relevant to the Budd-Chiari syndrome were discussed. There have been no serious complications of postoperative anticoagulation. Three patients, all of whom died, had recurrence of the Budd-Chiari syndrome. No other patient has had evidence of recurrent Budd-Chiari syndrome on postoperative liver biopsies. One-, 3-, and 5-year actuarial survival was 68.8%, 44.7%, and 44.7%, respectively. It was concluded that orthotopic liver transplantation is the most effective treatment for patients with the Budd-Chiari syndrome and end-stage liver disease.

Idioma originalEnglish (US)
Páginas (desde-hasta)43-49
Número de páginas7
PublicaciónAnnals of surgery
Volumen211
N.º1
DOI
EstadoPublished - 1990
Publicado de forma externa

ASJC Scopus subject areas

  • Surgery

Huella

Profundice en los temas de investigación de 'Liver transplantation for the Budd-Chiari syndrome'. En conjunto forman una huella única.

Citar esto